The largest database of trusted experimental protocols

Lomeguatrib

Manufactured by Selleck Chemicals
Sourced in United States

Lomeguatrib is a laboratory reagent used in biochemical research. It is a small organic compound that functions as a DNA repair inhibitor. The core function of Lomeguatrib is to disrupt the activity of a specific enzyme involved in DNA repair processes.

Automatically generated - may contain errors

4 protocols using lomeguatrib

1

Modulation of Temozolomide Sensitivity by MTH1

Check if the same lab product or an alternative is used in the 5 most similar protocols
To analyse the effect of MTH1 on the sensitivity of cells to the alkylating agent Temozolomide, which exerts its toxicity primarily through methylation of O6-guanine, we made use of two glioblastoma cell lines, U251 and U251-MTH1 in which the MTH1 gene had been deleted using CRISPR/Cas9. These two cell lines were kind gifts from Dr Massimo Squatrito. MTH1 knockout was verified using western blotting using rabbit anti-MTH1 (Novus Biologicals). Cells were seeded in MEM medium (Gibco), 10% FBS (Gibco), 50 μg/ml Pen/Strep (Gibco), 1% MEM Non-Essential Amino Acids Solution (100×) (Gibco) and 1 mM Sodium pyruvate (Gibco) and treated with DMSO, Temozolomide (15 μM, Sigma-Aldrich) or Lomeguatrib (20 μM, selleckchem.com) or with both Temozolomide (15 μM) and Lomeguatrib (20 μM). Caspase 3/7 activity was monitored as a measure of early apoptosis after 48 h of treatment (800 cells were seeded in each well of a 384-well plate) at eight different Temozolomide and Lomeguatrib concentrations ranging from 0 to 100 μM, using the Caspase-Glo 3/7 assay (Promega) according to the manufacturer's recommendations. For assessment of cell viability, 400 cells were seeded in each well of a 384-well plate and Temozolomide and Lomeguatrib were added as described for the apoptosis assay. Cell viability was measured after 96 h using Resazurin as previously described (22 (link)).
+ Open protocol
+ Expand
2

Culturing Patient-Derived Glioblastoma Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
The patient-derived GSCs were well characterized (Table 1) and cultured in NS-A medium (90% NeuroCult NS-A Basal Medium Human plus 10% Human NeuroCult NS-A proliferation Supplements, StemCell Technologies, Vancouver, British Columbia, Canada in 3D sphere as we described before [45 (link)]. Complete medium was supplied with recombinant human epidermal growth factor (R&D System, Minneapolis, MN, USA) and 100 units/mL penicillin-100 μg/mL streptomycin (Life Technologies, Carlsbad, CA, USA). Anti-TUSC3 and anti-MGMT antibodies were obtained from Abcam (Cambridge, United Kingdom); anti-β-actin IgG-HRP was obtained from Santa Cruz Biotech (Dallas, TX, USA) and anti-DNMT1, Goat anti-Rabbit IgG-HRP and Goat anti-mouse IgG-HRP were obtained from CellSignaling Technology (Danvers, MA, USA). Temozolomide (TMZ) was obtained from Sigma (St. Louis, MO, USA). 5-Azacitidine (5-Aza) and Lomeguatrib were obtained from Selleckchem (Houston, TX, USA).
+ Open protocol
+ Expand
3

Glioblastoma Stem Cell Line Establishment

Check if the same lab product or an alternative is used in the 5 most similar protocols
The GSC lines were established by isolating neurosphere-forming cells from fresh surgical specimens of human GBM tissue obtained from patients at The University of Texas MD Anderson Cancer Center from 2005 to 2008, as described previously.21 (link) Eight GSC lines [4 with MGMT-unmethylated/MGMT expression (MGMT+)] and [4 with MGMT-methylated/no MGMT expression (MGMT-)] were cultured in DMEM/F12 medium containing B27 supplement (Invitrogen), basic fibroblast growth factor, and epidermal growth factor. Short tandem repeats using the Applied Biosystems AmpFISTR Identifier kit were used to authenticate cells. The last authentication test was performed in July 2017. All cell lines tested negative for mycoplasma contamination using the MycoAlert Detection Kit.
TMZ was from Sigma–Aldrich and lomeguatrib, elimusertib, ceralasertib, and berzosertib were from Selleckchem. For in vitro use, all inhibitors were dissolved in dimethyl sulfoxide. For irradiation experiments, we performed photon irradiation using an X-RAD 320-Precision X-Ray Biological Radiator to deliver a precise dosage of 2 Gy to 12 Gy to the cultured cells. After irradiation, cells were transferred to a cell culture–grade incubator for downstream applications. Sham-treated cultures were kept in close proximity to the X-RAD device for the same amount of time without exposure to X-rays.
+ Open protocol
+ Expand
4

Inhibition of Sonic Hedgehog Pathway

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-Smo, anti-Gli1, and anti-MGMT antibodies were purchased from Abcam (Cambridge, UK). Anti-Cyclin D1 and anti-CDK-6 antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). The anti-β-actin antibody was purchased from Santa Cruz Biotechnology Inc. (Dallas, TX, USA), and GANT61, GDC0449, and lomeguatrib were obtained from Selleck Chemicals (Houston, TX, USA). The TMZ was purchased from J&K Scientific (Beijing, People’s Republic of China).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!